Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 2-dose vs 4-dose hydrocortisone replacement in primary adrenal insufficiency
2005-001768-30Phase 4Active
- Sponsor
- EM-kliniken
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydrocortisone in Addison's disease (2 arms), sponsored by EM-kliniken. Primary endpoints: Plasma ACTH and cortisol levels and Quality of life. Started Dec 2005; status: active.
02
Drugs
hydrocortisone
03
Conditions
Addison's disease
Beyond the preview
Go deeper on 2005-001768-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001768-30.